PRECIGEN INC
For the period ended Mar 31, 2024. Filed May 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 14, 2024
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Shareholders' Equity for the and
Condensed Consolidated Statements of Shareholders' Equity
| (Amounts in thousands, except share data) · Common Stock · Treasury Stock · AdditionalPaid-inCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · TotalShareholders'Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | ||||||||
| Balances at December 31, 2023 | 248,919,096 | $— | 7,479,431 | $— | $2,084,916 | $(1,947) | $(1,964,471) | $118,498 |
| Stock-based compensation expense | — | — | — | — | 2,581 | — | — | 2,581 |
| Shares issued upon vesting of restricted stock units | 961,534 | — | (961,534) | — | — | — | — | — |
| Shares issued as payment for services | 368,178 | — | (368,178) | — | 528 | — | — | 528 |
| Net loss | — | — | — | — | — | — | (23,738) | (23,738) |
| Other comprehensive loss | — | — | — | — | — | (850) | — | (850) |
| Balances at March 31, 2024 | 250,248,808 | $— | 6,149,719 | $— | $2,088,025 | $(2,797) | $(1,988,209) | $97,019 |
.
Condensed Consolidated Statements of Shareholders' Equity
| (Amounts in thousands, except share data) · Common Stock · Treasury Stock · AdditionalPaid-inCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · TotalShareholders'Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | ||||||||
| Balances at December 31, 2022 | 208,150,021 | $— | — | $— | $1,998,314 | $(3,488) | $(1,868,567) | $126,259 |
| Stock-based compensation expense | — | — | — | — | 3,131 | — | — | 3,131 |
| Shares issued upon vesting of restricted stock units and for exercises of stock options | 697,815 | — | — | — | — | — | — | — |
| Shares issued for accrued compensation | 2,206,469 | — | — | — | 3,361 | — | — | 3,361 |
| Shares issued as payment for services | 465,808 | — | — | — | 545 | — | — | 545 |
| Shares issued in public offerings, net of issuance costs | 43,962,640 | — | — | — | 72,782 | — | — | 72,782 |
| Net loss | — | — | — | — | — | — | (22,734) | (22,734) |
| Other comprehensive income | — | — | — | — | — | 789 | — | 789 |
| Balances at March 31, 2023 | 255,482,753 | $— | — | $— | $2,078,133 | $(2,699) | $(1,891,301) | $184,133 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.